Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 9.61
+0.22 (2.34%)
At close: Jul 3, 2026
-34.45% (1Y)
| Market Cap | 3.77B -43.5% |
| Revenue (ttm) | 659.54M -13.4% |
| Net Income | 100.78M -42.2% |
| EPS | 0.26 -41.6% |
| Shares Out | 392.08M |
| PE Ratio | 37.30 |
| Forward PE | n/a |
| Dividend | 0.20 (2.08%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 4,193,703 |
| Open | 9.39 |
| Previous Close | 9.39 |
| Day's Range | 9.34 - 9.74 |
| 52-Week Range | 8.45 - 17.14 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |